Home > Healthcare > Medical Devices > Medical Supplies > Intrauterine Devices Market

Intrauterine Devices Market Size

  • Report ID: GMI5451
  • Published Date: Aug 2024
  • Report Format: PDF

Intrauterine Devices Market Size

Intrauterine Devices Market size was valued at around USD 4.3 billion in 2023 and is expected to reach over USD 10.1 billion by 2032 at a CAGR of 10.3% from 2024 to 2032. The significantly high number of unintended pregnancies, favorable government initiatives and growing awareness are among the key factors driving the growth of the market.

 

Several factors contribute to these unintended pregnancies including social, economic, educational, and healthcare system issue. As per the United Nations Population Fund, nearly half of all pregnancies, totaling 121 million each year throughout the world, are unintended. IUDs are one of the most effective forms of reversible contraception available. They have a very low failure rate, with less than 1% chance of pregnancy per year of use for both hormonal and copper IUDs. This reliability makes them highly attractive to individuals seeking reliable birth control to avoid unintended pregnancies. These factors underscore the complex interplay of social, economic, educational, and healthcare system issues that contribute to the high rates of unintended pregnancies, and ultimately increases the intrauterine devices demand in the market.
 

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. These devices are made of flexible plastic and are designed to be a long-term, reversible form of birth control.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Intrauterine devices industry size was worth USD 4.3 billion in 2023 and will expand at 10.3% CAGR between 2024 and 2032, owing to the increasing awareness of long-term contraceptive options along with the rising demand for effective, reversible birth control methods.

The hormonal IUD segment registered USD 2.3 billion in 2023, propelled by its high efficacy, long-term protection, and additional health benefits, such as reduced menstrual bleeding and pain.

North America intrauterine devices industry achieved USD 1.5 billion in 2023 due to high awareness of reproductive health and widespread availability of advanced contraceptive options.

Major firms including Bayer AG, Contrel Europe, CooperSurgical Inc., Durbin, EUROGINE, S.L, Gima S.p.A., HLL Lifecare Limited, Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan N.V. (Viatris), OCON Medical Ltd., Pregna International Ltd., Prosan International BV, and SMB Corporation of India, are operating in the market.

Intrauterine Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 119
  • Countries covered: 23
  • Pages: 110
 Download Free Sample